Cardiology

The Department of Cardiovascular Medicine was established in 1952 and consists of the Department of Cardiology, Department of Hypertension, Institute of Cardiac Research of Shanghai Jiao Tong University School of Medicine, and Shanghai Institute of Hypertension. It is a national key discipline, a national clinical key specialty, and a member institution of the Shanghai Key Laboratory of Hypertension and the State Key Laboratory of Medical Genomics, ranking among the top ten in China’s hospital specialty rankings. The department has 350 operational beds, is equipped with 10 DSA units and internationally advanced instruments and equipment, and performs more than 10,000 coronary, pacing and electrophysiology, structural heart disease, and peripheral vascular interventional procedures annually. It took the lead in formulating the Chinese Guidelines for the Diagnosis and Treatment of Acute ST-Segment Elevation Myocardial Infarction, the Chinese Expert Consensus on Catheter Ablation of Atrial Fibrillation Using a Cryoballoon, the Chinese Guidelines for the Prevention and Treatment of Hypertension, the Chinese Guidelines for Ambulatory Blood Pressure Monitoring, and the Chinese Guidelines for Home Blood Pressure Monitoring. The department currently has 103 clinical physicians and full-time research personnel, with doctoral degree holders accounting for 85%, and includes 2 recipients of the National Natural Science Foundation of China Excellent Young Scientists Fund, 1 recipient of the Ministry of Education’s New Century Talent Program, 1 Shanghai Leading Talent, and multiple recipients of talent programs such as the Shanghai Silver Snake Award. It has 2 postdoctoral research stations, 12 doctoral supervisors, 14 master’s supervisors, and 68 enrolled master’s students, doctoral students, and postdoctoral fellows. Relying on the National Translational Medicine Large Facility Platform, the department specializes in ischemic myocardial injury and repair, hypertensive vascular remodeling, and metabolism and vascular biology, and is committed to mechanism research and translation of research achievements. Over the past 10 years, it has obtained more than 100 National Natural Science Foundation of China projects, including Key, Major, and Key International Cooperation projects, with cumulative research funding exceeding RMB 100 million. In the past 5 years, it has published 185 SCI papers in top journals, including Circulation (4 papers), JACC, Eur Heart J, Circ Res, ATVB, and Hypertension, with a cumulative impact factor of more than 800 points; it has applied for more than 20 patents, served as editor-in-chief or deputy editor-in-chief of 16 monographs, and received the second prize of the National Science and Technology Progress Award and more than 10 awards from the Ministry of Education and at the provincial and ministerial levels.